Dr. Adam M. Brufsky
Overview
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center. Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute. Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program.
Dr. Brufsky is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Gastrostomy.
His clinical research consists of co-authoring 328 peer reviewed articles and participating in 45 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles and participated in 1 clinical trial in the study of Metastatic Brain Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Halket Street, Suite 4628, Pittsburgh, PA 15213
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
39 Clinical Trials
UPMC Hillman Cancer Center
Shirley Ong, MD, specializes in hematology oncology and is board-certified in neurology by the American Board of Psychiatry and Neurology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ong received her medical degree from the University of the East Ramon Magsaysay Memorial Medical Center and completed her residency at Saint Louis University School of Medicine, followed by a fellowship at the University of Texas MD Anderson Cancer Center. Dr. Ong is rated as a Distinguished provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.
UPMC Hillman Cancer Center
Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.
UPMC Hillman Cancer Center
Kiran Kumar Rajasenan, MD, is a medical oncologist at UPMC Hillman Cancer Center, Wexford. Board-certified in internal medicine and medical oncology, Dr. Rajasenan received his medical degree from Hahnemann Medical College, now Drexel University College of Medicine in Philadelphia. He completed his residency at Allegheny General Hospital in Pittsburgh. Dr. Rajasenan is rated as an Advanced provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Non-Hodgkin Lymphoma, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Brufsky isElite. Learn about Breast Cancer.
- Triple-Negative Breast CancerDr. Brufsky isElite. Learn about Triple-Negative Breast Cancer.
- Distinguished
- AngiosarcomaDr. Brufsky isDistinguished. Learn about Angiosarcoma.
- Breast Cancer in MenDr. Brufsky isDistinguished. Learn about Breast Cancer in Men.
- Inflammatory Breast CancerDr. Brufsky isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Brufsky isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AgranulocytosisDr. Brufsky isAdvanced. Learn about Agranulocytosis.
- Bone TumorDr. Brufsky isAdvanced. Learn about Bone Tumor.
- Brain TumorDr. Brufsky isAdvanced. Learn about Brain Tumor.
- Febrile NeutropeniaDr. Brufsky isAdvanced. Learn about Febrile Neutropenia.
- HER2 Negative Breast CancerDr. Brufsky isAdvanced. Learn about HER2 Negative Breast Cancer.
- MenopauseDr. Brufsky isAdvanced. Learn about Menopause.
- Experienced
- ALK-Positive Non-Small Cell Lung CancerDr. Brufsky isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Anal CancerDr. Brufsky isExperienced. Learn about Anal Cancer.
- ChondrosarcomaDr. Brufsky isExperienced. Learn about Chondrosarcoma.
- Chronic Familial NeutropeniaDr. Brufsky isExperienced. Learn about Chronic Familial Neutropenia.
- DICER1 SyndromeDr. Brufsky isExperienced. Learn about DICER1 Syndrome.
- EGFR Positive Lung CancerDr. Brufsky isExperienced. Learn about EGFR Positive Lung Cancer.